Intellectual property, pharmaceuticals and public health : access to drugs in developing countries / edited by Kenneth C. Shadlen ... [et al.].

Format:

Book

Contributor:

Shadlen, Kenneth C.

Language:

English

Subjects (All):

Pharmaceutical industry--Developing countries.

Pharmaceutical industry.

Pharmaceutical services--Developing countries.

Pharmaceutical services.

Public health--Developing countries.

Public health.

Physical Description:

1 online resource (352 p.)

Place of Publication:

Northampton, Mass. : Edward Elgar, 2011.

Language Note:

English

Summary:

This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights. With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread a

Contents:

Cover; Copyright; Contents; Contributors; Acknowledgements; 1. Globalization, intellectual property rights, and pharmaceuticals: meeting the challenges to addressing health gaps in the new international environment; 2. Pharmaceutical production and access to essential medicines in South Africa; 3. Intellectual property and access to medicines: paradoxes in Moroccan policy; 4. The invisible threat: trade, intellectual property, and pharmaceutical regulations in Colombia; 5. The challenges of constructing pharmaceutical capabilities and promoting access to medicines in Mexico under TRIPS

6. Corporate power and state resistance: Brazil's use of TRIPS flexibilities for its National AIDS Program7. The politics of patents and drugs in Brazil and Mexico: the industrial bases of health policies; 8. Pharmaceutical patent policy in developing countries: learning from the Canadian experience; 9. Access to Indian generic drugs: emerging issues; 10. Sufficient but expensive drugs: a double-track system that facilitated supply capability in China

11. Access to essential drugs in Thailand: intellectual property rights and other institutional matters affecting public health in a developing country12. The TRIPS agreement and health innovation in Bangladesh; Index

Notes:

Description based upon print version of record.

Includes bibliographical references and index.

ISBN:

1-283-45793-8

9786613457936

0-85793-861-4

OCLC:

763159374